Single-agent bevacizumab is an effective treatment in recurrent glioblastoma (vol 32, 12, 2015)

Basit Öğe Kaydı
dc.authoridCicin, Irfan/0000-0002-7584-3868
dc.authoridHacıbekiroğlu, İlhan/0000-0002-0333-7405;
dc.authorwosidCicin, Irfan/AAQ-5575-2020
dc.authorwosidErdogan, Bulent/AAA-9781-2021
dc.authorwosidHacıbekiroğlu, İlhan/JCN-7264-2023
dc.authorwosidozcelik, melike/AAS-7557-2020
dc.contributor.authorHacibekiroglu, Ilhan
dc.contributor.authorKodaz, Hilmi
dc.contributor.authorErdogan, Bulent
dc.contributor.authorTurkmen, Esma
dc.contributor.authorOzcelik, Melike
dc.contributor.authorEsenkaya, Asim
dc.contributor.authorSaygi, Haci Mehmet
dc.date.accessioned2024-06-12T11:20:19Z
dc.date.available2024-06-12T11:20:19Z
dc.date.issued2015
dc.departmentTrakya Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.doi10.1007/s12032-015-0482-5
dc.identifier.issn1357-0560
dc.identifier.issn1559-131X
dc.identifier.issue4en_US
dc.identifier.pmid25782869en_US
dc.identifier.scopus2-s2.0-84925868429en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.urihttps://doi.org/10.1007/s12032-015-0482-5
dc.identifier.urihttps://hdl.handle.net/20.500.14551/25560
dc.identifier.volume32en_US
dc.identifier.wosWOS:000351474100033en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherHumana Press Incen_US
dc.relation.ispartofMedical Oncologyen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subject[No Keywords]en_US
dc.titleSingle-agent bevacizumab is an effective treatment in recurrent glioblastoma (vol 32, 12, 2015)en_US
dc.typeCorrectionen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu